This compound is a pharmaceutical raw material used as an oral anti-diabetic DPP-4 inhibitor. It is a small-molecule active pharmaceutical ingredient with a complex structure containing aromatic rings and polar functional groups, suitable for use in research and pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1108732-05-3
(S)-Alogliptin Benzoate Salt
active pharmaceutical ingredient
Entrectinib
active pharmaceutical ingredient
N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)(2,2,2-trifluoroacetyl)amino]Benzamide
active pharmaceutical ingredient
Roxatidine Hemioxalate
pharmaceutical intermediate for stomach medicine
Proinsulin C-Peptide (55-89) human
pharmaceutical raw material
2-[[6-[(3R)-3-aminopiperidin-1-yl]-2,4-dioxo-3-(trideuteriomethyl)pyrimidin-1-yl]methyl]benzonitrile
Pharmaceutical intermediate for alogliptin synthesis
Alogliptin (13CD3)
stable isotope labeled active pharmaceutical ingredient
Alogliptine
active pharmaceutical ingredient
2-[[6-[(3S)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile
ZSBOMTDTBDDKMP-HNNXBMFYSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@@H](C3)N